---
$id: https://graph.org.ai/products/commodity/51434809
$type: Product
source: UNSPSC
code: "51434809"
title: "Leptacline"
class: "51434800"
classTitle: "Antihypertensive drugs, synthesized"
family: "51430000"
familyTitle: "Antihypertensive drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Leptacline

**UNSPSC Code**: 51434809
**Class**: [Antihypertensive drugs, synthesized](Antihypertensive drugs, synthesized.mdx)
**Family**: [Antihypertensive drugs](../Antihypertensive drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antihypertensive agent with the molecular formula C12H23N, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5DXM29256P, chemically known as piperidine, 1-(cyclohexylmethyl)- but generally known as leptacline, which bears US NIH Compound Identifier 71660. European Medicines Agency schedules Leptacline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08436MIG. The term LEPTACLINE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 21 No. 12 1967, List 7). LEPTACLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule leptacline under HS 29333999 and SITC 51574. As of Q4 2014, LEPTACLINE remains the US FDA Preferred Term for this commodity. Leptacline bears US NLM identifiers UMLS ID C2825667 and NCI Concept Code C81523. SMILES: N1(CC2CCCCC2)CCCCC1.

